30 September 2024
Optima Health plc
("Optima Health" or the "Company")
Director / PDMR Shareholding
Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that it was notified on 27 September 2024, that Jonathan Thomas, (Chief Executive Officer of the Company) purchased 13,328 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 150 pence per share.
Following this, Jonathan Thomas holds an interest of 185,929 Ordinary Shares, representing approximately 0.21% of the current issued share capital.
Contacts:
| Optima Health |
|
| Jonathan Thomas, CEO Heidi Giles, CFO | +44(0)3300085113 media@OptimaHealth.co.uk |
|
|
|
| Nominated Adviser and Corporate Broker |
|
| Panmure Liberum Limited | +44 (0)20 3100 2000 |
| Emma Earl / Will Goode/ Mark Rogers / Rupert Dearden |
|
|
|
|
| UK Financial PR Adviser ICR Consilium Mary-Jane Elliott / Angela Gray / Chris Welsh | optimahealth@icrinc.com |
About Optima Health
Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Jonathan Thomas | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Chief Executive Officer | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| Optima Health plc | |||
| b)
| LEI
| 213800TOPWJSRCW4ON08 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each | |||
| | | ||||
| Identification code | GB00BRSCY602 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Purchase Price | Volume | | |
| | | 150 pence | 13,328 | | |
| | | | | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | 13,328 shares | ||||
| | 150 pence | ||||
| - Price | | ||||
| | | ||||
| e)
| Date of the transaction
| 27 September 2024 | |||
| f)
| Place of the transaction
| London Stock Exchange, AIM Market (XLON) | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
